Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-08-010500
Filing Date
2008-09-02
Accepted
2008-09-02 13:38:34
Documents
6
Effectiveness Date
2008-09-02

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL y71006defa14a.htm DEFA14A 47385
2 GRAPHIC y71006y7100600.gif GRAPHIC 361781
3 GRAPHIC y71006y7100601.gif GRAPHIC 42649
4 GRAPHIC y71006y7100602.gif GRAPHIC 22687
5 GRAPHIC y71006y7100603.gif GRAPHIC 30808
6 GRAPHIC y71006y7100604.gif GRAPHIC 65019
  Complete submission text file 0000950123-08-010500.txt   770127
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-09860 | Film No.: 081051121
SIC: 2834 Pharmaceutical Preparations